Reducing the Risk of MACE in T2DM with GLP-1RAs: Real World Considerations to Personalize Therapy
In this series, Dr. John B. Buse, Dr. Kathleen Dungan, and Dr. Christian T. Ruff present patient cases and share their personal approaches to reducing the risk of cardiovascular disease in diabetic patients. Using real-world evidence, they review cardiovascular risk stratification, the efficacy and safety of GLP-1 RA and cardiovascular outcomes trials, and COVID-19 implications as they develop a comprehensive treatment plan for a patient with cardiovascular risk factors.
Diabetes in the Setting of Cardiorenal Disease
Clinical CommentaryIn this activity, Dr. Kathleen Dungan and Dr. Christian T. Ruff present a patient case and share their personal approach to reducing the risk of cardiovascular disease in diabetic patients. They review cardiovascular risk stratification, cardiovascular outcomes trials, real-world evidence, and guideline recommendations as they develop a comprehensive treatment plan for a cardiorenal patient.
Faculty: Kathleen Dungan, MD, MPH; Christian T. Ruff, MD, MPH
Release Date:
Expiration Date: December 31, 2021
CME/CE is no longer available for this activity
Keep it Simple: A Compelling Indication for GLP-1 RAs in Diabetes
Clinical CommentaryIn this activity, Dr. John B. Buse and Dr. Christian T. Ruff present a patient case and share their personal approach to reducing the risk of cardiovascular disease in diabetic patients. They review the efficacy and safety of GLP-1 RA and cardiovascular outcomes trials as they walk through cardiovascular risk stratification and treatment selection for a patient with atherosclerotic cardiovascular disease.
Faculty: John B. Buse, MD, PhD; Christian T. Ruff, MD, MPH
Release Date:
Expiration Date: December 31, 2021
CME/CE is no longer available for this activity
Brave New World: Primary Prevention of CVD and T2DM
Clinical CommentaryIn this activity, Dr. Kathleen Dungan and Dr. Christian T. Ruff present a patient case and share their personal approach to reducing the risk of cardiovascular disease in diabetic patients. They review cardiovascular risk stratification, cardiovascular outcomes trials, and COVID-19 implications as they develop a comprehensive treatment plan for a patient with cardiovascular risk factors.
Faculty: Kathleen Dungan, MD, MPH; Christian T. Ruff, MD, MPH
Release Date:
Expiration Date: December 31, 2021
CME/CE is no longer available for this activity
